You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chronic HCV

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Hepatitis C Virus, Hepatitis C, Chronic, Hepatitis C Trial in Bucuresti (Bemnifosbuvir, Ruzasvir)

Recruiting
  • Chronic Hepatitis C Virus
  • +4 more
  • Bucuresti, BUC, Romania
    Atea Study Site
Jun 15, 2023

Chronic Hepatitis C, People Who Inject Drugs Trial in Atlanta (velpatasvir and sofosbuvir once daily for 12 weeks (brand or

Active, not recruiting
  • Chronic Hepatitis C
  • People Who Inject Drugs
  • velpatasvir and sofosbuvir once daily for 12 weeks (brand or branded generic) .
  • Atlanta, Georgia
    Wellstar Atlanta Medical Center
May 31, 2023

Hepatitis C Trial (Zinc Supplement)

Not yet recruiting
  • Hepatitis C
  • Zinc Supplement
  • (no location specified)
Jul 16, 2022

Coblopasvir Hydrochloride Capsules Combined With Sofosbuvir

Not yet recruiting
  • Hepatitis C Infection
    • Beijing, Bejing, China
      Bejing Tsinghua Changgung Hospital
    Oct 31, 2022

    Hepatitis C, Chronic, Opioid-use Disorder Trial in Pittsburgh (Sofosbuvir/Velpatasvir)

    Completed
    • Hepatitis C, Chronic
    • Opioid-use Disorder
    • Pittsburgh, Pennsylvania
      Magee Womens Hospital of UPMC
    Aug 19, 2022

    Long Term Follow up of Chronic HCV Patients Receiving DAAS

    Recruiting
    • Chronic Hepatitis c
      • Sohag, Egypt
        Sohag University Hospital
      Jun 29, 2022

      Hepatitis C Trial in Seoul

      Completed
      • Hepatitis C
        • Seoul, Korea, Republic of
          Local Institution
        Jan 6, 2022

        HCV Trial in Cairo (Sofosbuvir 200 MG Oral Tablet plus Daclatasvir 30 mg Oral tablets)

        Recruiting
        • HCV
        • Sofosbuvir 200 MG Oral Tablet plus Daclatasvir 30 mg Oral tablets
        • Cairo, Egypt
          Faculty of Medicine, Ain-Shams University Research Institute-Cli
        May 2, 2023

        Hepatitis C, Chronic Trial in Albuquerque (HCV RNA screening)

        Terminated
        • Hepatitis C, Chronic
        • HCV RNA screening
        • Albuquerque, New Mexico
        • +1 more
        Oct 26, 2022

        Hepatitis C, Chronic Trial in Taiwan (P1101 + Ribavirin)

        Recruiting
        • Hepatitis C, Chronic
        • P1101 + Ribavirin
        • Chiayi City, Taiwan
        • +7 more
        Jun 30, 2022

        Occult Hepatitis C Virus Infection in Patients Born Before 1969

        Not yet recruiting
        • Hepatitis C, Chronic
        • +2 more
        • Meridan Bioscience Point of Care test against HCV antibodies
        • (no location specified)
        Apr 2, 2023

        Eliminating HCV Infection Among PWUD

        Recruiting
        • Hepatitis C, Chronic
        • Drug Use
        • Vancouver, British Columbia, Canada
          Vancouver Infectious Diseases Centre
        Jul 22, 2022

        Chronic Hepatitis C Infection, HBV Coinfection, Hepatitis B Reactivation Trial in Hong Kong (Ledipasvir/Sofosbuvir, Sofosbuvir

        Completed
        • Chronic Hepatitis C Infection
        • +2 more
        • Hong Kong, Hong Kong, China
          Humanity and Health GI and Liver Centre
        Aug 27, 2021

        Hepatitis C Trial in Rotterdam (Peginterferon alfa-2a, Interferon alfa-2a, Ribavirin)

        Completed
        • Hepatitis C
        • Peginterferon alfa-2a
        • +2 more
        • Rotterdam, Netherlands
          Erasmus Medical Center
        Aug 26, 2021

        Chronic Hepatitis, Hepatitis C Infection Trial in Puerto Rico, United States (Electroporation-Mediated Plasmid DNA Vaccine

        Active, not recruiting
        • Chronic Hepatitis
        • Hepatitis C Infection
        • Electroporation-Mediated Plasmid DNA Vaccine Therapy
        • +4 more
        • Jacksonville, Florida
        • +4 more
        Sep 20, 2022

        End Stage Renal Disease, Chronic Hepatitis c Trial in Boston (Glecaprevir / Pibrentasvir Oral Tablet [Mavyret])

        Withdrawn
        • End Stage Renal Disease
        • Chronic Hepatitis c
        • Glecaprevir / Pibrentasvir Oral Tablet [Mavyret]
        • Boston, Massachusetts
          Massachusetts General Hospital
        Mar 4, 2022

        Hepatitis C Trial in Darlinghurst, Sydney, Adelaide (Sofosbuvir 400mg [Sovaldi], Glecaprevir/pibrentasvir (300mg/120mg))

        Recruiting
        • Hepatitis C
        • Sofosbuvir 400mg [Sovaldi]
        • Glecaprevir/pibrentasvir (300mg/120mg)
        • Darlinghurst, New South Wales, Australia
        • +2 more
        Mar 28, 2022

        Hepatitis C in Prison: Study of Screening and Rapid Treatment

        Not yet recruiting
        • Chronic HIV Infection
        • Xpert® HCV Viral test
        • FibroScan® test
        • Paris, France
          Internal Medicine Service, Cochin Hospital (Consultation and Amb
        Dec 10, 2022

        HCV RNA Fingerstick Assay as Useful Point of Care of Diagnostic

        Active, not recruiting
        • Hepatitis C, Chronic
        • GeneXpert HCV VL Fingerstick test
        • Bruxelles, Belgium
          CHU Saint-Pierre
        Feb 8, 2022

        Chronic HCV Infection Trial in China (HEC74647PA+HEC110114, Placebo)

        Recruiting
        • Chronic HCV Infection
        • Bengbu, Anhui, China
        • +35 more
        May 24, 2022

        Hepatitis C, Chronic, Opioid Dependence, on Agonist Therapy Trial in Bergen, Stavanger (Health care delivery)

        Active, not recruiting
        • Hepatitis C, Chronic
        • Opioid Dependence, on Agonist Therapy
        • Health care delivery
        • Bergen, Hordaland, Norway
        • +1 more
        Aug 5, 2022

        Hepatitis C Trial in Be'er Sheva, Petah Tikva (Direct acting anti-viral agents)

        Completed
        • Hepatitis C
        • Direct acting anti-viral agents
        • Be'er Sheva, Israel
        • +1 more
        Feb 17, 2021

        Chronic Hepatitis c Trial in Assiut (lipid profile, fasting insulin, fibro scan)

        Recruiting
        • Chronic Hepatitis c
        • lipid profile
        • +2 more
        • Assiut, Egypt
          Assiut University hospital
        Feb 23, 2022

        HCV Infection Trial in Germany, Netherlands, United States (ACH-0137171)

        Terminated
        • HCV Infection
        • Phoenix, Arizona
        • +8 more
        Sep 14, 2022

        Fixed-dose Combination Sofosdac® 400mg/60mg in Chronic Hepatitis

        Completed
        • Chronic Hepatitis c
        • Sofosdac®
        • Boufarik, Blida, Algeria
        • +3 more
        Nov 16, 2021